C. Michael Chaknos, MD, MSHP

Renal Electrolyte and Hypertension
Accepting new patients
Sees patients age 18 and up
Penn Renal Electrolyte and Hypertension Radnor
View 1 additional location
Schedule onlineCall 800-789-7366
Penn Medicine Provider

About me

  • Director, Renal Quality Improvement Program
  • Medical Director, Penn Medicine Radnor Dialysis Unit
  • Associate Professor of Clinical Medicine (Renal-Electrolyte and Hypertension)

My education and training

  • Medical School: Thomas Jefferson University
  • Residency: Tufts - New England Medical Center
  • Fellowship: University of Pennsylvania Health System

Spoken languages

English
English

Reviews

Average Rating

518 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
May 2026
explained well. sincere doctor. we trust him
Anonymous
May 2026
quality care and trust
Anonymous
April 2026
very knowledgeable medical information
Anonymous
April 2026
my provider is excellent. he explains everything to me and makes sure i understand. he makes sure i am okay with medication and the upkeep of my care.

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Chaknos is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

Michael R. Rudnick and C. Michael Chaknos Can Quality Improvement Reduce the Risk of Contrast-Associated Acute Kidney Injury? , Clinical Journal of the American Society of Nephrology: 2023

Anushya Jeyabalan MD, Shivam Joshi MD, Ankur Shah DO, Blaise Abramovitz DO, Anubhav Kumar MD, Alan Wasserstein MD, Jordana Cohen MD MSCE, C. Michael Chaknos MD MSHP, Dan Negoianu MD Improving CRRT Lifespan: A QI Initiative , Department of Medicine Research Day, Perelman School of Medicine: 2018

Anushya Jeyabalan MD, Shivam Joshi MD, Ankur Shah DO, Blaise Abramovitz DO, Anubhav Kumar MD, Alan Wasserstein MD, Jordana Cohen MD MSCE, C. Michael Chaknos MD MSHP, Dan Negoianu MD Improving CRRT Lifespan: A QI Initiative , Annual Meeting of the American Society of Nephrology, New Orleans, LA: 2017

Tiffany Wong, MD, C. Michael Chaknos, MD Improving the transition of care for dialysis patients between hospital discharge and return to the dialysis unit , National Kidney Foundation Spring Clinical Meeting, Orlando, FL: 2017

Seshasai Rebecca Kurnik, Mitra Nandita, Chaknos C Michael, Li Jiaqi, Wirtalla Christopher, Negoianu Dan, Glickman Joel D, Dember Laura M Factors Associated With Discontinuation of Home Hemodialysis. , American journal of kidney diseases : the official journal of the National Kidney Foundation, 67(4): 2016,629-37

Knauf F, Chaknos CM, Berns JS, Perazella MA Dabigatran and kidney disease: a bad combination , Clin J Am Soc Nephrol, 8(9): 2013,1591-7

Chaknos CM, Berns JB Erythropoesis Stimulating Agents on Trial: Are Higher Dosages Causing Harm? , American Journal of Kidney Diseases, 61(1): 2013,6-8

Chaknos CM, Berns JS Hypercalcemia , CURRENT Essentials of Nephrology and Hypertension: 2012

Chaknos CM, Berns JS Initiating dialysis at the right time: Is the evidence IDEAL? , Seminars in Dialysis, 23(6): 2010,627-9